Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): A potential treatment to prevent HCV reinfection in liver transplant patients

Rachel Eren, Dorit Landstein, Dov Terkieltaub, Ofer Nussbaum, Arie Zauberman, Judith Ben-Porath, Judith Gopher, Rachel Buchnick, Riva Kovjazin, Ziva Rosenthal-Galili, Sigal Aviel, Ehud Ilan, Yariv Shoshany, Lewis Neville, Tal Waisman, Ofer Ben-Moshe, Alberto Kischitsky, Steven K.H. Foung, Zhen Yong Keck, Orit PappoAhmed Eid, Oded Jurim, Gidi Zamir, Eithan Galun, Shlomo Dagan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): A potential treatment to prevent HCV reinfection in liver transplant patients'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences